Alliancebernstein L.P. Seelos Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.51 - $0.93 $21,063 - $38,409	-41,300 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.84 - $1.71 $168 - $342	200 Added 0.49%	41,300 $35,000
Q2 2021 Jul 30, 2021	BUY	$2.64 - $6.32 $108,504 - $259,752	41,100 New	41,100 $109,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $109M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.